Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP425564.RACPb7biZ0t4dxDAcbcTsKAQZJhVwndGtrxNc_T0rb_m0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP425564.RACPb7biZ0t4dxDAcbcTsKAQZJhVwndGtrxNc_T0rb_m0130_assertion type Assertion NP425564.RACPb7biZ0t4dxDAcbcTsKAQZJhVwndGtrxNc_T0rb_m0130_head.
- NP425564.RACPb7biZ0t4dxDAcbcTsKAQZJhVwndGtrxNc_T0rb_m0130_assertion description "[The African American Study of Kidney Disease and Hypertension provided evidence that an angiotensin-converting enzyme inhibitor-based treatment program is more beneficial than calcium channel blockers and beta blockers in reducing the progression of renal failure in blacks with hypertensive nephropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP425564.RACPb7biZ0t4dxDAcbcTsKAQZJhVwndGtrxNc_T0rb_m0130_provenance.
- NP425564.RACPb7biZ0t4dxDAcbcTsKAQZJhVwndGtrxNc_T0rb_m0130_assertion evidence source_evidence_literature NP425564.RACPb7biZ0t4dxDAcbcTsKAQZJhVwndGtrxNc_T0rb_m0130_provenance.
- NP425564.RACPb7biZ0t4dxDAcbcTsKAQZJhVwndGtrxNc_T0rb_m0130_assertion SIO_000772 14688494 NP425564.RACPb7biZ0t4dxDAcbcTsKAQZJhVwndGtrxNc_T0rb_m0130_provenance.
- NP425564.RACPb7biZ0t4dxDAcbcTsKAQZJhVwndGtrxNc_T0rb_m0130_assertion wasDerivedFrom befree-2016 NP425564.RACPb7biZ0t4dxDAcbcTsKAQZJhVwndGtrxNc_T0rb_m0130_provenance.
- NP425564.RACPb7biZ0t4dxDAcbcTsKAQZJhVwndGtrxNc_T0rb_m0130_assertion wasGeneratedBy ECO_0000203 NP425564.RACPb7biZ0t4dxDAcbcTsKAQZJhVwndGtrxNc_T0rb_m0130_provenance.